Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe honest answer about Wegovy side effects is this: most people experience some gastrointestinal symptoms, particularly in the first few weeks after starting or after a dose increase, and the large majority describe them as manageable rather than unbearable. That picture comes from both the clinical trial record and the real-world side effects reviews that have accumulated since Wegovy launched. As a prescription-only medicine, semaglutide requires a clinical assessment before any prescriber can issue it — what you've read in reviews is a starting point, not a substitute for that conversation. Our prescribers discuss side effects and individual suitability as part of every consultation at nume's free consultation — sorry, at our free consultation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Scroll through any collection of Wegovy side effects reviews and a pattern emerges quickly, nausea dominates, especially in early months, and experiences vary sharply from person to person. The instinct is to read that variability as unpredictability. It isn't quite that. What you're actually seeing is dose titration playing out across different people at different speeds.
Semaglutide slows gastric emptying, which is part of how it reduces appetite. The same mechanism produces nausea, reflux, and that particular heavy fullness that reviews describe as feeling "stuffed after two bites". The graduated dosing schedule (0.25mg rising through 0.5mg, 1.0mg, 1.7mg, and up to 2.4mg, each step held for roughly four weeks) exists specifically to reduce that impact. Most people who pushed through an unpleasant patch around a dose increase report that symptoms settled within one to two weeks. That timeline appears consistently across both the STEP 1 trial data and the broader pattern in community reviews.
The NHS semaglutide medicines page lists the common effects clearly: nausea, vomiting, diarrhoea, constipation, indigestion, burping, fatigue, headache and injection-site reactions. None of this is hidden or downplayed in the licensed information. What reviewers add is texture, which meals made nausea worse, what time of day suited them for injecting, how long the fatigue actually lasted. That texture is genuinely useful. It isn't a substitute for the clinical picture, but it isn't worthless either.
For a fuller breakdown of the reported frequency and grading of individual effects, our Wegovy side effects overview covers the trial data in detail.
Not every side effects review is about mild inconvenience. A smaller but meaningful proportion of people describe more severe nausea, persistent vomiting bad enough to affect hydration, or abdominal pain that didn't follow the usual early-weeks pattern. This is where the reading-reviews-for-reassurance habit runs into a real limit.
Severe, persistent stomach pain (particularly if it radiates toward the back, with or without vomiting) is a symptom that needs urgent medical review. Acute pancreatitis is a known but infrequent risk with GLP-1 medicines. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting this, advising patients and prescribers to be alert to these symptoms and to stop the medicine and seek help promptly if they occur. The update sits on the MHRA Drug Safety Update index.
Other symptoms worth contacting a doctor for promptly: signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat), gallbladder pain (right-side upper abdominal pain, sometimes with fever or jaundice), or significant dehydration from repeated vomiting or diarrhoea. These are not the experiences that dominate most Wegovy reviews, but they appear, and reading about them in a forum is not the same as being assessed.
People sometimes wonder whether their side effects are "normal" when they differ from what they've read. That question is exactly what a prescriber is there to answer. The consultation with our clinical team includes an explicit discussion of your specific risk profile, not a generic side-effect checklist.
Community reviews of Wegovy's side effects cluster around the GI effects because those are immediate and hard to ignore. Two areas that appear far less often in lay reviews but matter clinically: hair thinning and changes in mood or sleep, both of which some people experience during significant weight loss regardless of the method.
Hair shedding associated with rapid weight loss (telogen effluvium) tends to appear three to six months in, and reviewers who encounter it are sometimes alarmed. It's a known physiological response to calorie reduction and weight change, not a direct pharmacological effect of semaglutide. Our look at Wegovy and hair loss goes through the evidence on this specifically.
A second gap in most reviews: what happens when side effects are genuinely absent. Some people move through the full titration without significant nausea or fatigue and spend time wondering whether the medicine is working. The absence of side effects does not indicate the medicine isn't active. Our page on experiencing no side effects on Wegovy addresses this directly.
Consumer-reported experience also varies by dose in ways that raw review numbers don't always make clear. The consumer reports breakdown and our summary of the five most commonly reported Wegovy side effects both add structure to what can otherwise feel like a noise-heavy landscape of individual accounts.
As a prescription medicine, Wegovy is dispensed through a GPhC-registered pharmacy following clinical sign-off. The cost and access picture for private treatment is covered on our Wegovy price comparison page if that's a factor in your thinking.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.